Marro and coworkers reported that inhibition of IFN-α by using an antibody or a selective sphingosine-1-phosphate receptor 1 (S1PR1) agonist (CYM-5442) prevented T1D in mouse model and described the regulation mechanism. This evidence concerns the gene S1PR1 and type 1 diabetes mellitus.